经验

Asymchem Laboratories – HK$7.15 Billion IPO

December 15, 2021

Cooley advised Asymchem Laboratories, a contract development manufacturing organization (CDMO) serving the global pharmaceutical industry, on its HK$7.15 billion (US$916 million) initial public offering – marking the largest healthcare IPO in Hong Kong this year – of 18,415,400 H shares, which now trade on the Hong Kong Stock Exchange. Partners Yiming Liu and Michael Yu led the Cooley team advising Asymchem.

Read more

Related contacts

刘毅铭
上海办事处主管合伙人, 上海
余仙
香港办事处主管合伙人, 香港
王一盈
顾问律师, 上海
杨凯婷
顾问律师, 香港
武梦超
律师, 北京
Cindy Pan
International Legal Project Manager, 香港
Rick Jantz
Associate, 洛杉矶
Francis Wheeler
Senior Counsel, 科罗拉多

Related Practices & Industries

Huitongda Network – HK$2.2 Billion IPO

February 19, 2022

Cooley advised the joint sponsors and underwriters on ecommerce company Huitongda’s HK$2.2 billion (US$285 million) initial public offering of 51,606,200 H shares on the Hong Kong Stock Exchange, subject to the exercise of the underwriters’ option to purchase an additional 7,740,900 H shares. Partners Michael Yu and Will Cai led the Cooley team advising the joint sponsors and underwriters.

Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
袁晓通
资深顾问律师, 北京
杨凯婷
顾问律师, 香港
段棣淳
律师, 北京
武梦超
律师, 北京
Jingxian Huang
Associate, 北京
王冰清
国际法律项目经理, 上海
Francis Wheeler
Senior Counsel, 科罗拉多
Eric Blanchard
Partner, 波士顿
Kevin King
Partner, 华盛顿特区
Karen Tsai
Special Counsel, 华盛顿特区

Related Practices & Industries

Fenbi – HK$198 Million IPO

January 11, 2023

Cooley advised the underwriters for Fenbi, an internet-born test preparation company, on its proposed listing of shares on the Main Board of the Stock Exchange of Hong Kong Limited. Partners Ethan Jin, Michael Yu and Will Cai led the Cooley team.

Read more

Related contacts

金朝
合伙人, 上海
余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
袁晓通
资深顾问律师, 北京
武梦超
律师, 北京
王帅文
国际法律项目经理, 北京
刘学谦
律师, 香港
Francis Wheeler
Senior Counsel, 科罗拉多

Related Practices & Industries

PATEO Announces HK$1.07 Billion IPO

September 30, 2025

Cooley advised PATEO CONNECT Technology (Shanghai) Corporation, a pioneer in smart cockpit and internet of vehicles solutions in China’s automotive industry, on its HK$1.07 billion initial public offering (IPO).

Read more

Related contacts

金朝
合伙人, 上海
蔡华
合伙人, 香港
袁晓通
资深顾问律师, 北京
武梦超
律师, 北京
Kevin King
Partner, 华盛顿特区
Karen Tsai
Special Counsel, 华盛顿特区
Jingxian Huang
Associate, 北京
徐云翔
律师, 上海

Related Practices & Industries

Innogen Pharmaceutical Announces HK$682.87 Million IPO

August 15, 2025

Cooley advised Innogen Pharmaceutical on its HK$682.87 million initial public offering (IPO).

Read more

Related contacts

金朝
合伙人, 上海
刘毅铭
上海办事处主管合伙人, 上海
武梦超
律师, 北京
李涵
注册外国律师(纽约), 香港
徐云翔
律师, 上海

Related Practices & Industries

查看全部

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.